Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Girard

Showing results (71-80 of 396) with videos related to

Pageof 40
Sort By:
JFMS Open Reports|August 22, 2022
Nasopharyngeal sialocoele with underlying auditory tube neoplasia in a catJulien Fritz, Audrey Belmudes, Edouard Cauvin, et al.
Lung Cancer (Amsterdam, Netherlands)|October 5, 2022
Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approachClémence Basse, Hédi Chabanol, Pierre-Emmanuel Bonte, et al.
Cancer Management and Research|August 16, 2019
Optimal management of thymic malignancies: current perspectivesGabrielle Drevet, Stéphane Collaud, François Tronc, et al.
Bulletin Du Cancer|September 24, 2021
[Establishing at a shared and common educational assessment at Curie Institute]Carole Kalogéropoulos, Silène Delorme, Claire Llambrich-Molines, et al.
La Revue Du Praticien|December 5, 2018
[Thymic tumors]Nicolas Girard, Claire Merveilleux Du Vignaux, Thierry Molina, et al.
The Journal of Clinical Investigation|April 21, 2011
Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in miceMaxime Cazorla, Joël Prémont, Andre Mann, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trialNicolas Girard, Françoise Mornex, Nadine Bossard, et al.
Journal of Inflammation (London, England)|March 3, 2015
Anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 beta®) in joint diseasesCatherine Baugé, Eva Lhuissier, Nicolas Girard, et al.
The Journal of Sexual Medicine|July 29, 2019
The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX)Stanley Althof, Ian H Osterloh, Gary J Muirhead, et al.
The Journal of Organic Chemistry|November 19, 2010
Hydroformylation of alkenylamines. Concise approaches toward piperidines, quinolizidines, and related alkaloidsEtienne Airiau, Nicolas Girard, Marianna Pizzeti, et al.
Pageof 40

Showing results (71-80 of 396) with videos related to

Sort By:
Pageof 40
JFMS Open Reports|August 22, 2022
Nasopharyngeal sialocoele with underlying auditory tube neoplasia in a catJulien Fritz, Audrey Belmudes, Edouard Cauvin, et al.
Lung Cancer (Amsterdam, Netherlands)|October 5, 2022
Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approachClémence Basse, Hédi Chabanol, Pierre-Emmanuel Bonte, et al.
Cancer Management and Research|August 16, 2019
Optimal management of thymic malignancies: current perspectivesGabrielle Drevet, Stéphane Collaud, François Tronc, et al.
Bulletin Du Cancer|September 24, 2021
[Establishing at a shared and common educational assessment at Curie Institute]Carole Kalogéropoulos, Silène Delorme, Claire Llambrich-Molines, et al.
La Revue Du Praticien|December 5, 2018
[Thymic tumors]Nicolas Girard, Claire Merveilleux Du Vignaux, Thierry Molina, et al.
The Journal of Clinical Investigation|April 21, 2011
Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in miceMaxime Cazorla, Joël Prémont, Andre Mann, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2010
Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trialNicolas Girard, Françoise Mornex, Nadine Bossard, et al.
Journal of Inflammation (London, England)|March 3, 2015
Anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 beta®) in joint diseasesCatherine Baugé, Eva Lhuissier, Nicolas Girard, et al.
The Journal of Sexual Medicine|July 29, 2019
The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX)Stanley Althof, Ian H Osterloh, Gary J Muirhead, et al.
The Journal of Organic Chemistry|November 19, 2010
Hydroformylation of alkenylamines. Concise approaches toward piperidines, quinolizidines, and related alkaloidsEtienne Airiau, Nicolas Girard, Marianna Pizzeti, et al.
Pageof 40